Reviews in Urology
Editorial Board
MEDICAL EDITOR
Michael K. Brawer MD
URIDEA
Dr. Brawer is Chief Executive Officer of URIDEA in Seattle, WA, and formerly Professor of Urology and Adjunct Professor, Department of Pathology, at the University of Washington. A frequent principal investigator in benign and neoplastic proliferative disorders, he cofounded Reviews in Urology, serves on the boards of 12 other journals, and has published over 300 articles, books, and abstracts.
Herbert Lepor MD
New York University School of Medicine
Known for his pioneering work in the surgical management of prostate cancer and the physiology and pharmacology of benign prostatic disorders, Dr. Lepor is cofounder of Reviews in Urology. He is Professor and Martin Spatz Chairperson of Urology and Professor of Pharmacology at New York University School of Medicine in New York, NY.
ASSOCIATE EDITOR
Victor W. Nitti MD
New York University School of Medicine
Expertise: Female Urology
An authority on urodynamic techniques and medical and surgical therapies for incontinence and voiding dysfunction in women and men, Dr. Nitti has authored numerous peer-reviewed articles and book chapters on these subjects, edited the textbook Practical Urodynamics, and is on the editorial board of Neurourology and Urodynamics, International Urogynecology Journal, and the Journal of Pelvic Medicine & Surgery Dr. Nitti is Associate Professor and Vice Chairman of Urology and Director of Voiding Dysfunction and Female Urology at New York University School of Medicine.
EDITORIAL BOARD MEMBER
Dean G. Assimos MD
Wake Forest University School of Medicine
Expertise: Kidney Stones
An internationally recognized leader in all aspects of managing patients with nephrolithiasis, Dr. Assimos is Professor of Surgical Sciences (Urology) and Head of the Section of Endourology, Nephrolithiasis, and Laparoscopy at Wake Forest University School of Medicine in Winston-Salem, North Carolina. He is a member of the American Urological Association Nephrolithiasis Guidelines Committee and is currently conducting clinical and basic science research on oxalate metabolism.
Arie S. Belldegrun MD, FACS
The David Geffen School of Medicine at UCLA
Expertise: Advanced Prostate Cancer
A leading clinical urologic oncologist with expertise in drug development and clinical trials, immunotherapy, and targeted therapy for genitourinary cancers, Dr. Belldegrun is professor and Chief of Urologic Oncology and holds the Doumani Chair in urologic oncology at The David Geffen School of Medicine at UCLA in Los Angeles, CA.
Michael B. Chancellor MD
William Beaumont Hospital
Expertise: Incontinence
Michael B. Chancellor, MD, is the Director of Neurourology Program in the Department of Urology at the William Beaumont Hospital in Royal Oak, MI. Dr. Chancellor has written over 550 peer-reviewed articles and book chapters in journals including The Journal of Urology, Urology, Gene Therapy, and Lancet. He has also written 11 books and serves on the editorial board of 12 scientific journals. Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering, drug discovery, and was the first urologist to use botulinum toxin to treat lower urinary tract dysfunction.
Bob Djavan MD, PhD
University of Brussels
Expertise: BPH (Device)
An expert in the management of prostate cancer, benign prostatic hyperplasia, and treatment options, Dr. Djavan is Professor and Chairman of the Department of Urology at the University of Brussels in Brussels, Belgium. He is also affiliated with Erasme Hospital, University Clinics of Brussels.
Steven A. Kaplan MD
Weill Cornell Medical College of Cornell University
Expertise: Neurourology, BPH, Female Urology
A recognized authority on benign disease of the prostate and female urology, Dr. Kaplan is Professor of Urology and Chief of The Institute of Bladder and Prostate Health at Weill Cornell Medical College of Cornell University in New York, NY. Dr. Kaplan is on the editorial boards of Urology and The Journal of Urology, and is Editor in Chief of Current Prostate Reports.
Randall B. Meacham MD
University of Colorado School of Medicine
Expertise: Androgen Replacement and Infertility
An authority in the area of male reproductive medicine and surgery, Dr. Meacham program director of the Rocky Mountain Urological Society. He also serves as co-moderator of Androlog, an Internet-based group for clinicians and scientists involved in the diagnosis and treatment of male infertility. Dr. Meacham is Professor, Residency Program Director, and Head of the Division of Urology at the University of Colorado School of Medicine in Denver, CO.
J. Curtis Nickel MD, FRCSC
Queen's University
Expertise: Prostatitis
A respected researcher in the fields of inflammatory diseases of the urinary tract and benign diseases of the prostate, Dr. Nickel is Professor of Urology at Queen’s University in Kingston, Ontario, Canada, and CIHR Canada Research Chair in Urologic Pain and Inflammation. He directs the Prostatitis and Interstitial Cystitis Clinical Research Center and BPH Clinical Research at the Kingston Center for Applied Urological Research.
Alan W. Partin MD, PhD
Johns Hopkins
Expertise: Prostate Cancer
A prominent researcher on benign prostatic hyperplasia and prostate cancer, with a current focus on new prostate cancer serum markers, Dr. Partin is the David Hall McConnell Professor and Director of Urology at The Johns Hopkins Medical Institutions and The Johns Hopkins Hospital in Baltimore, MD. He is also the editor of Campbell-Walsh Urology.
Jacob Rajfer MD
University of California at Los Angeles
Expertise: Erectile Dysfunction
Recognized for his work in the areas of male infertility and erectile dysfunction, Dr. Rajfer is Professor of Urology in the Department of Urology at the University of California at Los Angeles. He is also Chief of Urology at Harbor-UCLA Medical Center in Torrance, CA.
Claus G. Roehrborn MD, FACS
University of Texas Southwestern Medical Center at Dallas
Expertise: BPH (Med)
A clinician and researcher recognized for his contributions to the study of benign and malignant prostate diseases, Dr. Roehrborn is Professor and Chairman of the Department of Urology at The University of Texas Southwestern Medical Center at Dallas. He is on multiple editorial boards, is Associate Editor of Urology, and author of over 300 peer-reviewed publications, mostly in the field of prostatic diseases.
Ellen Shapiro MD, FACS, FAAP
New York University School of Medicine
Expertise: Pediatric Urology
Professor and Director of Pediatric Urology at New York University School of Medicine, Dr. Shapiro is known for her contributions to pediatric urology, especially in the area of fetal bladder, prostate, and urethral development. She serves on the American Urological Association Guideline Panel for Vesicoureteral Reflux. Dr. Shapiro also serves on the editorial committee of the Pediatric Section of the Journal of Urology.
Kevin M. Slawin MD
Vanguard Urologic Institute
Expertise: Advanced Prostate Cancer
With a combined focus on prostate disease research and treatment, Dr. Slawin is founder and Director of the Vanguard Urologic Institute and the Texas Prostate Center in Houston, TX. He is a member of the Center for Clinical and Translational Sciences at the University of Texas Health Science Center at Houston, Clinical Professor of Urology at Baylor College of Medicine, and Director of Urology at Memorial Hermann Hospital, Texas Medical Center.
David Sussman DO, FACOS
University of Medicine and Dentistry of New Jersey
Expertise: Female Urology and Voiding Dysfunction
In addition to general urology, Dr. Sussman's specific areas of expertise include female urology and voiding dysfunction and large group socioeconomic issues. Dr. Sussman is a clinical associate professor of the Department of Surgery, Division of Urology at the University of Medicine and Dentistry of New Jersey and has served as past Chief of Staff at Kennedy Health System. He is Head of Urology at Kennedy Health System, Washington Township Campus. Dr. Sussman is past president of the urology section of the American College of Osteopathic Surgeons and Section Head of Female Urology.